Do discussions of financial burdens decrease long-term financial toxicity in adolescent and young adult cancer survivors?


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
03 Jul 2023
Historique:
received: 30 01 2023
accepted: 16 05 2023
medline: 5 7 2023
pubmed: 3 7 2023
entrez: 3 7 2023
Statut: epublish

Résumé

This study aims to evaluate the associations between patient-provider cost discussions with patient-reported out-of-pocket (OOP) spending and long-term financial toxicity (FT) among adolescent and young adult (AYA; 15-39 years old) cancer survivors. Using a cross-sectional survey, we assessed the themes and quality of patient discussions with providers about financial needs and general survivorship preparation, quantified patients' levels of FT, and evaluated patient-reported OOP spending. We determined the association between cancer treatment cost discussion and FT using multivariable analysis. In a subset of survivors (n = 18), we conducted qualitative interviews and used thematic analysis to characterize responses. Two hundred forty-seven AYA survivors completed the survey at a mean of 7 years post treatment and with a median COST score of 13. 70% of AYA survivors did not recall having any cost discussion about their cancer treatment with a provider. Having any cost discussion with a provider was associated with decreased FT (β = 3.00; p = 0.02) but not associated with reduced OOP spending (χ2 = 3.77; p = 0.44). In a second adjusted model, with OOP spending included as a covariate, OOP spending was a significant predictor of FT (β =  - 1.40; p = 0.002). Key qualitative themes included survivors' frustration about the lack of communication related to financial issues throughout treatment and in survivorship, feeling unprepared, and reluctance to seek help. AYA patients are not fully informed about the costs of cancer care and FT; the dearth of cost discussions between patients and providers may represent a missed opportunity to reduce costs.

Identifiants

pubmed: 37395811
doi: 10.1007/s00520-023-07822-3
pii: 10.1007/s00520-023-07822-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

434

Subventions

Organisme : Memorial Sloan Kettering Medical Student Summer Research Fellowship
ID : NIH/NCI 5R25CA020449
Organisme : NIH/NCI Cancer Center Support Grant P30
ID : CA008748

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

De Moor JS, Williams CP, Blinder VS (2022) Cancer-related care costs and employment disruption: recommendations to reduce patient economic burden as part of cancer care delivery. J Natl Cancer Inst Monogr 2022:79. https://doi.org/10.1093/JNCIMONOGRAPHS/LGAC006
doi: 10.1093/JNCIMONOGRAPHS/LGAC006 pubmed: 35788373 pmcid: 9255940
De Moor JS, Kent EE, McNeel TS et al (2021) Employment outcomes among cancer survivors in the United States: implications for cancer care delivery. JNCI J Nat Cancer Ins 113:641. https://doi.org/10.1093/JNCI/DJAA084
doi: 10.1093/JNCI/DJAA084
Wu J, Moss H (2023) Financial toxicity in the post-health reform era. J Am Coll Radiol 20:10–17. https://doi.org/10.1016/J.JACR.2022.09.036
doi: 10.1016/J.JACR.2022.09.036 pubmed: 36509218
Kayser K, Smith L, Washington A et al (2021) Living with the financial consequences of cancer: a life course perspective. J Psychosoc Oncol 39:17–34. https://doi.org/10.1080/07347332.2020.1814933
doi: 10.1080/07347332.2020.1814933 pubmed: 32876547
Di Giuseppe G, Pagalan L, Jetha A, et al (2023) Financial toxicity among adolescent and young adult cancer survivors: a systematic review of educational attainment, employment, and income. Crit Rev OncolHematol 183:. https://doi.org/10.1016/J.CRITREVONC.2023.103914
Ghazal LV, Gormley M, Merriman JD, Santacroce SJ (2021) Financial toxicity in adolescents and young adults with cancer: a concept analysis. Cancer Nurs 44:E636–E651. https://doi.org/10.1097/NCC.0000000000000972
doi: 10.1097/NCC.0000000000000972 pubmed: 34694089
Salsman JM, Bingen K, Barr RD, Freyer DR (2019) Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults. Pediatr Blood Cancer 66:e27660. https://doi.org/10.1002/PBC.27660
doi: 10.1002/PBC.27660 pubmed: 30756484 pmcid: 6777708
Austin JD, Robertson MC, Shay LA, Balasubramanian BA (2019) Implications for patient-provider communication and health self-efficacy among cancer survivors with multiple chronic conditions: results from the Health Information National Trends Survey. J Cancer Surviv 13:663–672. https://doi.org/10.1007/S11764-019-00785-7
doi: 10.1007/S11764-019-00785-7 pubmed: 31309416 pmcid: 6832747
Blanch-Hartigan D, Chawla N, Moser RP et al (2016) Trends in cancer survivors’ experience of patient-centered communication: results from the Health Information National Trends Survey (HINTS). J Cancer Surviv 10:1067–1077. https://doi.org/10.1007/S11764-016-0550-7
doi: 10.1007/S11764-016-0550-7 pubmed: 27193357
Reed SC, Walker R, Ziebell R et al (2018) Cancer survivors’ reported discussions with health care providers about follow-up care and receipt of written care plans. J Cancer Educ 33:1181–1188. https://doi.org/10.1007/S13187-017-1228-1
doi: 10.1007/S13187-017-1228-1 pubmed: 28480500
Rai A, Chawla N, Han X et al (2019) Has the quality of patient-provider communication about survivorship care improved? J Oncol Pract 15:e916–e924. https://doi.org/10.1200/JOP.19.00157
doi: 10.1200/JOP.19.00157 pubmed: 31265350 pmcid: 6851794
Chawla N, Blanch-Hartigan D, Virgo KS et al (2016) Quality of patient-provider communication among cancer survivors: findings from a nationally representative sample. J Oncol Pract 12:e964–e973. https://doi.org/10.1200/JOP.2015.006999
doi: 10.1200/JOP.2015.006999 pubmed: 27221992 pmcid: 5455584
Hong YR, Salloum RG, Yadav S et al (2020) Patient-provider discussion about cancer treatment costs and out-of-pocket spending: implications for shared decision making in cancer care. Value Health 23:1592–1598. https://doi.org/10.1016/J.JVAL.2020.08.002
doi: 10.1016/J.JVAL.2020.08.002 pubmed: 33248514
Perni S, Azoba C, Gorton E, et al (2022) Financial toxicity, symptom burden, illness perceptions, and communication confidence in cancer clinical trial participants. JCO Oncol Pract OP2100697. https://doi.org/10.1200/OP.21.00697
Hofstatter EW (2010) Understanding patient perspectives on communication about the cost of cancer care: a review of the literature. J Oncol Pract 6:188–192. https://doi.org/10.1200/JOP.777002
doi: 10.1200/JOP.777002 pubmed: 21037869 pmcid: 2900868
Zafar SY (2016) Financial toxicity of cancer care it’s time to intervene. JNCI J Nat Cancer Inst 108:370. https://doi.org/10.1093/JNCI/DJV370
doi: 10.1093/JNCI/DJV370
Zafar SY, Chino F, Ubel PA et al (2015) The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care 21:607–615
pubmed: 26618364
Hartnett CS, Furstenberg FF, Birditt KS, Fingerman KL (2013) Parental support during young adulthood: why does assistance decline with age?. J Fam Issues 34:975–1007. https://doi.org/10.1177/0192513X12454657
doi: 10.1177/0192513X12454657 pubmed: 23976811 pmcid: 3747833
Nichols HM, Dababnah S, Berger Z, et al (2021) Can you hear me now? Effects of patient-centered communication with young adults aged 26 to 39. J Patient Exp 8:. https://doi.org/10.1177/23743735211033116
Zebrack B, Kent EE, Keegan THM et al (2014) “Cancer sucks”, and other ponderings by adolescent and young adult cancer survivors. J Psychosoc Oncol 32:1–15. https://doi.org/10.1080/07347332.2013.855959
doi: 10.1080/07347332.2013.855959 pubmed: 24428248 pmcid: 3902666
Harris PA, Taylor R, Minor BL, et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:. https://doi.org/10.1016/J.JBI.2019.103208
Thom B, Benedict C, Friedman DN et al (2021) Economic distress, financial toxicity, and medical cost-coping in young adult cancer survivors during the COVID-19 pandemic: findings from an online sample. Cancer 127:4481–4491. https://doi.org/10.1002/CNCR.33823
doi: 10.1002/CNCR.33823 pubmed: 34351638
Medical Expenditure Panel Survey (MEPS): experiences with cancer survivorship supplement. https://healthcaredelivery.cancer.gov/meps/ . Accessed 21 Dec 2022
de Souza JA, Yap BJ, Hlubocky FJ et al (2014) The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer 120:3245–3253. https://doi.org/10.1002/CNCR.28814
doi: 10.1002/CNCR.28814 pubmed: 24954526
de Souza JA, Yap BJ, Wroblewski K et al (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123:476. https://doi.org/10.1002/CNCR.30369
doi: 10.1002/CNCR.30369 pubmed: 27716900
Anderson AS, Mackison D, Boath C, Steele R (2013) Promoting changes in diet and physical activity in breast and colorectal cancer screening settings: an unexplored opportunity for endorsing healthy behaviors. Cancer Prev Res (Phila) 6:165–172. https://doi.org/10.1158/1940-6207.CAPR-12-0385
doi: 10.1158/1940-6207.CAPR-12-0385 pubmed: 23324132
Deppen SA, Grogan EL, Aldrich MC, Massion PP (2014) Lung cancer screening and smoking cessation: a teachable moment? J Natl Cancer Inst 106:. https://doi.org/10.1093/JNCI/DJU122
Gray CM, Hunt K, Lorimer K et al (2011) Words matter: a qualitative investigation of which weight status terms are acceptable and motivate weight loss when used by health professionals. BMC Public Health 11:1–9. https://doi.org/10.1186/1471-2458-11-513/TABLES/2
doi: 10.1186/1471-2458-11-513/TABLES/2
Dee EC, Chino F (2022) Financial hardship in cancer care-the need to define and intervene on actionable metrics. JAMA Netw Open 5:E2223149. https://doi.org/10.1001/JAMANETWORKOPEN.2022.23149
doi: 10.1001/JAMANETWORKOPEN.2022.23149 pubmed: 35877128
Meeker CR, Wong YN, Egleston BL et al (2017) Distress and financial distress in adults with cancer: an age-based analysis. J Natl Compr Canc Netw 15:1224–1233. https://doi.org/10.6004/JNCCN.2017.0161
doi: 10.6004/JNCCN.2017.0161 pubmed: 28982748 pmcid: 7569506
The costs of cancer | American Cancer Society cancer action network. https://www.fightcancer.org/costs-cancer . Accessed 30 Jul 2022
Salsman JM, Kircher SM (2022) Financial hardship in adolescent and young adult oncology: the need for multidimensional and multilevel approaches. JCO Oncol Pract 18:173–176. https://doi.org/10.1200/op.21.00663
doi: 10.1200/op.21.00663 pubmed: 34807736
ASCO cancer treatment and survivorship care plans. https://www.cancer.org/treatment/survivorship-during-and-after-treatment/long-term-health-concerns/survivorship-care-plans.html . Accessed 3 Aug 2022
Adolescent and Young Adult (AYA) Oncology Guidelines. https://www.nccn.org/professionals/physician_gls/pdf/aya.pdf . Accessed 3 Aug 2022
M H, SL W, JV S (2003) Childhood cancer survivorship: improving care and quality of life. https://doi.org/10.17226/10767
Janssen SHM, van der Graaf WTA, van der Meer DJ, et al (2021) Adolescent and Young Adult (AYA) Cancer survivorship practices: an overview. Cancers (Basel) 13:. https://doi.org/10.3390/CANCERS13194847
Jones JM, Fitch M, Bongard J et al (2020) The needs and experiences of post-treatment adolescent and young adult cancer survivors. J Clin Med 9:1444. https://doi.org/10.3390/JCM9051444
doi: 10.3390/JCM9051444 pubmed: 32413981 pmcid: 7291222
Rocque GB, Williams CP, Miller HD et al (2019) Impact of travel time on health care costs and resource use by phase of care for older patients with cancer. J Clin Oncol 37:1935. https://doi.org/10.1200/JCO.19.00175
doi: 10.1200/JCO.19.00175 pubmed: 31184952 pmcid: 6804875
Isshiki T, Kimura Y, Takei N et al (2013) Estimation of travel time and costs required for patients with cancer to receive outpatient treatment using electronic medical record data. J Clin Oncol 31:270–270. https://doi.org/10.1200/JCO.2013.31.31_SUPPL.270
doi: 10.1200/JCO.2013.31.31_SUPPL.270
Pisu M, Azuero A, McNees P et al (2010) The out of pocket cost of breast cancer survivors: a review. J Cancer Surviv 4:202–209. https://doi.org/10.1007/S11764-010-0125-Y
doi: 10.1007/S11764-010-0125-Y pubmed: 20401542 pmcid: 2922410
Shih YCT, Smieliauskas F, Geynisman DM et al (2015) Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011. J Clin Oncol 33:2190–2196. https://doi.org/10.1200/JCO.2014.58.2320
doi: 10.1200/JCO.2014.58.2320 pubmed: 25987701 pmcid: 4477789
Kaddas HK, Pannier ST, Mann K et al (2020) Age-related differences in financial toxicity and unmet resource needs among adolescent and young adult cancer patients. J Adolesc Young Adult Oncol 9:105. https://doi.org/10.1089/JAYAO.2019.0051
doi: 10.1089/JAYAO.2019.0051 pubmed: 31524556 pmcid: 7047093
Marjerrison S, Barr RD (2018) Unmet survivorship care needs of adolescent and young adult cancer survivors. JAMA Netw Open 1:e180350–e180350. https://doi.org/10.1001/JAMANETWORKOPEN.2018.0350
doi: 10.1001/JAMANETWORKOPEN.2018.0350 pubmed: 30646082
Davies LM, Hayhurst KP, Lorigan P, Molassiotis A (2018) Unmet supportive care needs, health status and minimum costs in survivors of malignant melanoma. Eur J Cancer Care (Engl) 27:. https://doi.org/10.1111/ECC.12811
Albright BB, Nitecki R, Chino F et al (2022) Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States. Am J Obstet Gynecol 226:384.e1-384.e13. https://doi.org/10.1016/J.AJOG.2021.09.034
doi: 10.1016/J.AJOG.2021.09.034 pubmed: 34597606
Kent EE, de Moor JS, Zhao J et al (2020) Staying at one’s job to maintain employer-based health insurance among cancer survivors and their spouses/partners. JAMA Oncol 6:929–932. https://doi.org/10.1001/JAMAONCOL.2020.0742
doi: 10.1001/JAMAONCOL.2020.0742 pubmed: 32324208 pmcid: 7180727
Kirchhoff AC, Nipp R, Warner EL et al (2018) “Job lock” among long-term survivors of childhood cancer: a report from the childhood cancer survivor study. JAMA Oncol 4:707–711. https://doi.org/10.1001/JAMAONCOL.2017.3372
doi: 10.1001/JAMAONCOL.2017.3372 pubmed: 29049517

Auteurs

Victoria S Wu (VS)

Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Catherine Benedict (C)

Stanford University School of Medicine, Stanford Cancer Institute, Palo Alto, CA, USA.

Danielle N Friedman (DN)

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Samantha E Watson (SE)

Expect Miracles Foundation, Boston, MA, USA.

Evanie Anglade (E)

Rutgers New Jersey Medical School, Newark, NJ, USA.

Michelle S Zeitler (MS)

Expect Miracles Foundation, Boston, MA, USA.

Fumiko Chino (F)

Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Bridgette Thom (B)

Affordability Working Group, Memorial Sloan Kettering Cancer Center, New York, NY, USA. thomb@mskcc.org.
Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. thomb@mskcc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH